Sageview Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Sageview Capital’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-222,334	Closed	-$11.9M	–	6
2014 Q1	$11.9M	Hold	222,334	–	–	3.76%	3
2013 Q4	$5.6M	Hold	222,334	–	–	1.59%	5
2013 Q3	$6.05M	Hold	222,334	–	–	1.81%	7
2013 Q2	$8.03M	Buy	+222,334	New	+$8.34M	2.18%	6

Other funds holding PTX

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return